Related Experiment Videos
Effects of various antineoplastic agents on an established human melanoma cell line (G-361)
J M García Reverte1, A Bernabeu Esclapez, J Muñoz Ramos
1Department of Pathology, Faculty of Medicine, University of Murcia, Spain.
Abstract:
An established human melanoma cell line was treated with several concentrations of three antineoplastic drugs: melphalan (0.016, 0.032, 0.16 microns), CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) (0.04, 0.21, 0.42 microM), and 4-OHA (4-hydroxyanisole) (4.01 x 10(-4), 1.20 x 10(-3), 2.4 x 10(-3) microM), and the effects on cell growth and viability were compared. 24 hours after treatment, 4-OHA (ID50 = 2.4 x 10(-3) microM) was more cytotoxic than melphalan (ID50 = 0.016 microM) and CCNU (ID50 = 0.21 microM). However, after 96 hours exposure, the most effective drug was CCNU (growth rate = -1.277), which caused the death of the culture. This was followed by melphalan (growth rate = -1.024) and finally 4-OHA (growth rate = -0.69). Similar ultrastructural cell injuries were observed after the use of the three drugs: the dilation of endoplasmic reticulum vesicles and the nuclear membrane; mitochondria swelling; and the existence of lamellar structures and cytoplasmic vacuoles.
Insights
Melphalan, CCNU, and 4-hydroxyanisole (4-OHA) show varying effectiveness against melanoma cells over time. CCNU proved most potent after 96 hours, inducing significant cell death and ultrastructural damage.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Melanoma is a significant public health concern, necessitating novel therapeutic strategies.
- Antineoplastic drugs are crucial in cancer treatment, but their efficacy can vary.
- Understanding drug-induced cellular responses is key to optimizing cancer therapy.
Purpose of the Study:
- To compare the cytotoxic effects of melphalan, CCNU, and 4-hydroxyanisole (4-OHA) on a human melanoma cell line.
- To evaluate the time-dependent efficacy of these antineoplastic agents.
- To investigate the ultrastructural changes induced by these drugs in melanoma cells.
Main Methods:
- Treatment of a human melanoma cell line with varying concentrations of melphalan, CCNU, and 4-OHA.
- Assessment of cell growth and viability at 24 and 96 hours post-treatment.
- Microscopic examination to identify ultrastructural cellular injuries.
Main Results:
- At 24 hours, 4-OHA exhibited higher cytotoxicity (ID50 = 2.4 x 10(-3) microM) compared to melphalan (ID50 = 0.016 microM) and CCNU (ID50 = 0.21 microM).
- After 96 hours, CCNU demonstrated the greatest efficacy (growth rate = -1.277), leading to culture death, followed by melphalan (growth rate = -1.024) and 4-OHA (growth rate = -0.69).
- Common ultrastructural injuries included endoplasmic reticulum and nuclear membrane dilation, mitochondrial swelling, and formation of lamellar structures and cytoplasmic vacuoles.
Conclusions:
- The efficacy of antineoplastic drugs against melanoma cells is concentration- and time-dependent.
- CCNU shows superior long-term cytotoxic effects on melanoma cells compared to melphalan and 4-OHA.
- These drugs induce characteristic cellular damage, suggesting common mechanisms of action at the ultrastructural level.